Niagen Bioscience, Inc.
NAGE- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001386570
No open-market purchases or sales by Niagen Bioscience, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $102.1M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Niagen Bioscience, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +5 vs. Q1 2021
- Shares held
- 20.4M
- −2.20M (−9.7%) vs. Q1 2021
- Total value
- $201.0M
- −$9.95M (−4.7%) vs. Q1 2021
- New holders
- 19
- 37 more added
- Sold out
- 14
- 28 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 139 | $102.1M |
| Q1 2026 | 143 | $162.3M |
| Q4 2025 | 169 | $204.8M |
| Q3 2025 | 162 | $296.1M |
| Q2 2025 | 155 | $417.8M |
| Q1 2025 | 139 | $172.0M |
| Q4 2024 | 123 | $119.3M |
| Q3 2024 | 91 | $64.3M |
| Q2 2024 | 79 | $45.2M |
| Q1 2024 | 67 | $45.7M |
| Q4 2023 | 53 | $16.5M |
| Q3 2023 | 54 | $16.4M |
| Q2 2023 | 55 | $17.7M |
| Q1 2023 | 59 | $18.1M |
| Q4 2022 | 59 | $19.1M |
| Q3 2022 | 62 | $15.0M |
| Q2 2022 | 75 | $25.3M |
| Q1 2022 | 82 | $49.9M |
| Q4 2021 | 83 | $75.9M |
| Q3 2021 | 86 | $129.0M |
| Q2 2021 | 101 | $201.0M |
| Q1 2021 | 96 | $211.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Niagen Bioscience, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Yong Rong (HK) Asset Management Ltd | 4,131,317 | $40.7M | 10.13% | 00.0% | Unchanged |
| Norges Bank | 0 | $0 | 0.00% | −555,800−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −208,000−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −98,765−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −84,400−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −76,651−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −22,886−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −19,886−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −12,820−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −12,125−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,802−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,215−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −2,029−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,168−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |